Published 14 hours ago

US awards Moderna US$176 million to produce bird flu vaccine

The US government has awarded Moderna US$176 million to develop its bird flu vaccine amid concerns of H5N1 virus outbreaks in dairy cows and infections in dairy workers since March.
Moderna will utilize the funds from the US Biomedical Advanced Research and Development Authority to complete late-stage development and testing of an mRNA-based vaccine against H5N1 avian influenza.
The agreement with Moderna also includes provisions for preparing and responding to future public health threats.

Insights by Ground AI

Does this summary seem wrong?

0 Articles

All

Left

Center

Right

BBC News

US pays millions to Moderna to develop bird flu vaccine

Moderna is being given $176 million to work on a bird flu vaccine in case there is ever a human pandemic.

13 hours ago·United Kingdom

Read Full Article

Reuters

US awards Moderna $176 million to produce bird flu vaccine

The U.S. government has awarded $176 million to Moderna to advance development of its bird flu vaccine, the company said on Tuesday, as concerns rise over a multi-state outbreak of H5N1 virus in dairy cows and infections of three dairy workers since March.

17 hours ago·United Kingdom

Read Full Article

Associated Press News

US will pay Moderna $176 million to develop an mRNA pandemic flu vaccine

The U.S. government will pay Moderna $176 million to develop a pandemic vaccine that could be used to treat bird flu in people.

15 hours ago·United States

Read Full Article

abc News

The US will pay Moderna $176 million to develop an mRNA pandemic flu vaccine

The U.S. government will pay the vaccine maker Moderna $176 million to develop a pandemic vaccine that could be used to treat bird flu in people as cases in dairy cows continue to mount across the country

15 hours ago·United States

Read Full Article

CNN

US government inks a deal with Moderna to make pandemic flu vaccine

The US Department of Health and Human Services announced Tuesday a contract with Moderna to develop an mRNA vaccine that targets pandemic flu, in case the shot becomes necessary with the latest outbreak of bird flu.

10 hours ago·Atlanta, United States

Read Full Article